Aprepitant for the Treatment of Pruritus in Sézary Syndrome: A Randomized Crossover Clinical Trial
Zic JA, Straka BT, McGirt LY, Nian H, Yu C, Brown NJ. Aprepitant for the Treatment of Pruritus in Sézary Syndrome: A Randomized Crossover Clinical Trial. JAMA Dermatology 2018, 154: 1221-1222. PMID: 30140912, PMCID: PMC6233739, DOI: 10.1001/jamadermatol.2018.2510.Peer-Reviewed Original ResearchAgedAprepitantCross-Over StudiesDouble-Blind MethodFemaleHumansMaleMiddle AgedNeurokinin-1 Receptor AntagonistsPruritusSezary SyndromeSkin NeoplasmsTreatment Failure